|
NO167087C
(no)
|
1985-10-25 |
1991-10-02 |
Secr Defence Brit |
Fremgangsmaate for fremstilling av en nitratester.
|
|
US5561227A
(en)
|
1991-07-23 |
1996-10-01 |
Schering Corporation |
Process for the stereospecific synthesis of azetidinones
|
|
LT3300B
(en)
|
1992-12-23 |
1995-06-26 |
Schering Corp |
Combination of a cholesterol biosynhtesis inhibitor and a beta- lactam cholesterol absorbtion inhibitor
|
|
CA2228647A1
(en)
|
1995-09-01 |
1997-03-13 |
Pharmacia & Upjohn Company |
Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings
|
|
WO2000005214A2
(en)
|
1998-07-24 |
2000-02-03 |
Pfizer Inc. |
Isoquinolines as urokinase inhibitors
|
|
ATE439131T1
(de)
|
2001-08-30 |
2009-08-15 |
Chemocentryx Inc |
Bicyclische verbindungen als hemmer der chemokin- bindung an us28
|
|
ATE452879T1
(de)
|
2002-07-12 |
2010-01-15 |
Sanofi Aventis Deutschland |
Heterozyklisch substituierte benzoylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
|
JP4516430B2
(ja)
|
2002-12-20 |
2010-08-04 |
メルク・シャープ・エンド・ドーム・コーポレイション |
１−（アミノ）インダン並びに（１，２−ジヒドロ−３−アミノ）−ベンゾフラン、ベンゾチオフェン及びインドール
|
|
JP4660199B2
(ja)
|
2002-12-23 |
2011-03-30 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
置換１−ピペリジン−４−イル−４−アゼチジン−３−イル−ピペラジン誘導体およびそれらのニューロキニン拮抗薬としての使用
|
|
GB0510204D0
(en)
|
2005-05-19 |
2005-06-22 |
Chroma Therapeutics Ltd |
Enzyme inhibitors
|
|
US7790707B2
(en)
*
|
2006-03-21 |
2010-09-07 |
Epix Pharmaceuticals Inc. |
S1P receptor modulating compounds and use thereof
|
|
JP5043120B2
(ja)
|
2006-10-30 |
2012-10-10 |
クロマ セラピューティクス リミテッド |
ヒストンデアセチラーゼの阻害剤としてのヒドロキサメート
|
|
US20090137549A1
(en)
|
2006-11-09 |
2009-05-28 |
Paul John Edward |
Novel compounds useful for the treatment of degenerative & inflamatory diseases
|
|
WO2010056788A1
(en)
|
2008-11-17 |
2010-05-20 |
Merck Sharp & Dohme Corp. |
Anti-hypercholesterolemic compounds
|
|
CN102388048B
(zh)
|
2009-02-10 |
2014-07-30 |
阿斯利康(瑞典)有限公司 |
三唑并[4，3-b]哒嗪衍生物及其用于前列腺癌的用途
|
|
WO2011036889A1
(ja)
|
2009-09-25 |
2011-03-31 |
武田薬品工業株式会社 |
複素環化合物
|
|
GB201002563D0
(en)
|
2010-02-15 |
2010-03-31 |
Cambridge Entpr Ltd |
Compounds
|
|
NZ603876A
(en)
|
2010-05-13 |
2015-02-27 |
Amgen Inc |
Nitrogen heterocyclic compounds useful as pde10 inhibitors
|
|
MX2012013128A
(es)
|
2010-05-13 |
2013-03-20 |
Amgen Inc |
Compuestos heterociclicos de nitrogeno como inhibidores de la fosfodiesterasa 10.
|
|
WO2012082947A1
(en)
|
2010-12-16 |
2012-06-21 |
Irm Llc |
Compounds and compositions as tgr5 agonists
|
|
EP2545964A1
(en)
|
2011-07-13 |
2013-01-16 |
Phenex Pharmaceuticals AG |
Novel FXR (NR1H4) binding and activity modulating compounds
|
|
EP2855457A1
(en)
|
2012-05-09 |
2015-04-08 |
Zoetis Products LLC |
Azetidine derivatives as antiparasitic agents
|
|
AR092348A1
(es)
|
2012-07-11 |
2015-04-15 |
Hoffmann La Roche |
DERIVADOS DE ARIL-SULTAMO COMO MODULADORES DE RORc
|
|
BR112015010649A2
(pt)
|
2012-11-16 |
2017-07-11 |
Bristol Myers Squibb Co |
moduladores de gpr40 à base de pirrolidina
|
|
WO2015055771A1
(en)
|
2013-10-17 |
2015-04-23 |
AbbVie Deutschland GmbH & Co. KG |
Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
CA2934700A1
(en)
|
2014-01-06 |
2015-07-09 |
Rhizen Pharmaceuticals Sa |
Glutaminase inhibitors
|
|
FR3017867A1
(fr)
*
|
2014-02-21 |
2015-08-28 |
Inventiva |
Nouveaux composes de type phenylazetidine carboxylate ou carboxamide
|
|
TR201809633T4
(tr)
|
2014-05-07 |
2018-07-23 |
Bristol Myers Squibb Co |
Diyabet gibi hastalıkların tedavisine yönelik pirolidin GPR40 modülatörleri.
|
|
EP3191453B1
(en)
|
2014-09-09 |
2019-10-23 |
Bristol-Myers Squibb Company |
Phenyl-(aza)cycloalkyl carboxylic acid gpr120 modulators
|
|
US11219625B2
(en)
|
2015-07-24 |
2022-01-11 |
Yale University |
Inhibitors of N-linked glycosylation and methods using same
|
|
CA3001666C
(en)
|
2015-10-12 |
2021-03-30 |
Chong Kun Dang Pharmaceutical Corp. |
Oxadiazole amine derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
|
|
ES2975689T3
(es)
*
|
2016-01-29 |
2024-07-11 |
Ono Pharmaceutical Co |
Derivado de tetrahidronaftaleno
|
|
PT3426243T
(pt)
|
2016-03-09 |
2021-08-19 |
Raze Therapeutics Inc |
Inibidores de 3-fosfoglicerato desidrogenase e utilizações dos mesmos
|
|
WO2017205425A1
(en)
|
2016-05-24 |
2017-11-30 |
President And Fellows Of Harvard College |
Compounds for organic light emitting diode materials
|
|
BR112018075734A2
(pt)
|
2016-06-13 |
2019-04-02 |
Gilead Sciences, Inc. |
composto, composição farmacêutica, método para tratar um paciente com uma doença ou condição mediada pelo menos em parte por fxr, e, uso de um composto.
|
|
CA3252823A1
(en)
|
2016-06-13 |
2025-02-25 |
Gilead Sciences, Inc. |
Substituted tert-butyl-3-(2-chloro-phenyl)-3-hydroxyazetidine-1-carboxylate compounds
|
|
WO2018106818A1
(en)
|
2016-12-07 |
2018-06-14 |
Kura Oncology, Inc. |
Methods of promoting beta cell proliferation
|
|
AR110988A1
(es)
|
2017-02-21 |
2019-05-22 |
Sanofi Sa |
Compuestos de azetidina como moduladores de gpr119 para el tratamiento de la diabetes, la obesidad, la dislipidemia y trastornos relacionados
|
|
JP7365332B2
(ja)
|
2017-08-07 |
2023-10-19 |
ジョイント・ストック・カンパニー “バイオキャド” |
Ｃｄｋ８／１９阻害薬としての新規ヘテロ環式化合物
|
|
JP7281469B2
(ja)
|
2018-01-19 |
2023-05-25 |
イドーシア ファーマシューティカルズ リミテッド |
Ｃ５ａ受容体調節剤
|
|
EP3837252B1
(en)
|
2018-08-16 |
2025-12-10 |
Boehringer Ingelheim International GmbH |
Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors
|
|
MX2021001857A
(es)
|
2018-08-17 |
2021-10-13 |
Genentech Inc Star |
Metodos de diagnostico y terapeuticos para el tratamiento del cancer de mama.
|
|
JPWO2020071550A1
(ja)
|
2018-10-04 |
2021-09-24 |
京都薬品工業株式会社 |
Ｃｄｋ８阻害剤およびその用途
|
|
US11179383B2
(en)
|
2018-10-30 |
2021-11-23 |
Gilead Sciences, Inc. |
Compounds for inhibition of α4β7 integrin
|
|
CN111484479B
(zh)
|
2019-01-25 |
2023-06-13 |
四川科伦博泰生物医药股份有限公司 |
氮杂环化合物、包含其的药物组合物及其制备方法和用途
|
|
JP7669299B2
(ja)
|
2019-07-03 |
2025-04-28 |
エフ． ホフマン－ラ ロシュ アーゲー |
複素環モノアシルグリセロールリパーゼ（ｍａｇｌ）阻害剤
|
|
ES2983098T3
(es)
*
|
2019-08-20 |
2024-10-22 |
Ono Pharmaceutical Co |
Sal y forma cristalina de un compuesto que tiene actividad agonista por el receptor de S1P5
|
|
CN112887914A
(zh)
*
|
2019-11-30 |
2021-06-01 |
深圳市海思半导体有限公司 |
终端间定位方法及装置
|
|
CN111704613B
(zh)
|
2020-06-23 |
2021-07-06 |
中国人民解放军军事科学院军事医学研究院 |
咪唑类衍生物及其作为trpv4抑制剂的用途
|
|
US12624003B2
(en)
|
2020-12-23 |
2026-05-12 |
Celgene Corporation |
Carboxylic acid containing indanyl compounds for the treatment of neurodegenerative diseases
|
|
CA3217423A1
(en)
*
|
2021-06-16 |
2022-12-22 |
Jeffrey M. Schkeryantz |
Azetidinyl compounds comprising a carboxylic acid group for the treatment of neurodegenerative diseases
|